History of DSM-5 in Timeline

The DSM-5 is the American Psychiatric Association's diagnostic tool for mental disorders, updated in 2013, with a revised version (DSM-5-TR) published in 2022. It is the primary authority for psychiatric diagnoses in the US, influencing treatment and insurance coverage. Unlike previous editions, it uses an Arabic numeral and is a 'living document'. While crucial, some professionals and researchers may utilize the ICD or symptom scale scores instead. Its updates have significant practical implications in mental health.

1999: DSM-5 Research Planning Conference

In 1999, the American Psychiatric Association (APA) and the National Institute of Mental Health (NIMH) jointly sponsored a DSM-5 Research Planning Conference. The goal was to establish research priorities that would inform and shape the development of the DSM-5. Research Planning Work Groups created "white papers" on various topics.

2003: Campaign to Change Borderline Personality Disorder Designation

In 2003, the Treatment and Research Advancements National Association for Personality Disorders (TARA-APD) campaigned to change the name and designation of borderline personality disorder in DSM-5, proposing names like "emotional regulation disorder" or "emotional dysregulation disorder." There was also discussion about moving it from an Axis II to an Axis I diagnosis.

2004: White Papers Due

By 2004, three additional white papers were due concerning gender issues, diagnostic issues in the geriatric population, and mental disorders in infants and young children, expanding the research base informing the DSM-5 development.

July 23, 2007: DSM-5 Task Force Announcement

On July 23, 2007, the American Psychiatric Association (APA) announced the members of the DSM-5 Task Force, which consisted of 27 members. The task force oversaw the development of the DSM-5 and included researchers, clinicians, and advocates. Members were required to disclose any competing interests.

May 2008: Controversial Taskforce Appointments

In May 2008, the appointment of Kenneth Zucker and Ray Blanchard to the DSM-5 taskforce resulted in an internet petition calling for their removal. Concerns were raised regarding Zucker's research and theories related to gender identity in children.

June 2009: Allen Frances Criticizes DSM-5 Process

In June 2009, Allen Frances voiced strong criticisms regarding the development process of DSM-5. He expressed concerns about the potential for unintended consequences and the closed, secretive nature of the task force's work, stating that the work on DSM-V has displayed the most unhappy combination of soaring ambition and weak methodology.

2009: Concerns About Industry Influence

In 2009, concerns were raised regarding industry influence on the DSM-5 task force. It was noted that a significant percentage of task force members had direct ties to the industry, leading to questions about transparency and potential conflicts of interest.

June 2011: British Psychological Society's Concerns

In June 2011, the British Psychological Society responded to draft versions of the DSM-5, expressing significant concerns. It criticized the proposed diagnoses as being based on social norms and subjective judgments, raising doubts about the reliability, validity, and overall value of the existing criteria.

November 2011: Society for Humanistic Psychology Letter

In November 2011, psychologist Brent Robbins co-authored a national letter for the Society for Humanistic Psychology that brought thousands into the public debate about the DSM. Approximately 13,000 individuals and mental health professionals signed a petition in support of the letter. Concerns were raised that the new guidelines could pathologize normal human experiences like grief.

2012: Grief vs. Depression Distinction Added

In 2012, in response to criticisms, a footnote was added to the draft text of the DSM-5. It explained the distinction between grief and depression, addressing concerns about potentially misclassifying normal grief as a pathological disorder.

April 29, 2013: NIMH Director's Blog Post

On April 29, 2013, the director of the National Institute of Mental Health (NIMH), Thomas R. Insel, MD, wrote a blog post regarding the DSM-5.

May 2013: NIMH and APA Joint Statement

In May 2013, Insel, representing NIMH, and Jeffrey A. Lieberman, president of the American Psychiatric Association, issued a joint statement. The statement emphasized that the DSM-5 represented the best available information for diagnosing mental disorders, but also clarified that the DSM-5 and Research Domain Criteria (RDoC) are complementary frameworks, not competing ones.

2013: DSM-5 Publication

In 2013, the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) was published as an update to the DSM. It serves as the principal authority for psychiatric diagnoses in the United States, influencing treatment recommendations and health insurance coverage.

2015: Criticism for Poor Cultural Diversity

In 2015, an essay from an Australian university criticized the DSM-5 for lacking cultural diversity. The essay argued that cognitive sciences and cognitive anthropology predominantly accept Western psychology as the norm, which limits the DSM-5's applicability across diverse cultural contexts.

2015: Criticism of Biological Underpinnings

In 2015, the DSM-5 received criticism for allegedly not addressing the biological foundations of mental disorders. A comprehensive book assessing the DSM-5, featuring contributions from philosophers, historians, and anthropologists, was also published.

March 2022: DSM-5-TR Published

In March 2022, a revision of DSM-5, titled DSM-5-TR, was published, updating diagnostic criteria and ICD-10-CM codes. The diagnostic criteria for avoidant/restrictive food intake disorder were changed, along with adding entries for prolonged grief disorder, unspecified mood disorder, and stimulant-induced mild neurocognitive disorder.

2022: DSM-5-TR Publication

In 2022, a revised version of the DSM-5, called DSM-5-TR, was published. This updated version included changes to diagnostic criteria and ICD-10-CM codes.